New Developments in Neuromyelitis Optica Spectrum Disorder: Expert Guidance on Diagnosis, Treatment Strategies, and the Patient Perspective

Wednesday, June 01, 2022

8:00 PM – 9:15 PM CME Symposium

Program Features:

  • Interactive, case-based learning environment
  • Create your own Personalized Poster

Agenda

  • Challenges in the Diagnosis of Patients with NMOSD
    • Clinical characteristics
    • NMOSD lesions: involvement of the spinal cord, optic nerve, area postrema, diencephalon, brain stem, cerebrum
    • Diagnostic methodologies
      • Guidelines
      • Red flags for diagnosis
      • AQP4-IgG assays
      • Adult vs pediatric diagnosis
    • Differential diagnosis/other autoimmune diseases with similar features
  • NMOSD: Epidemiology and Pathophysiology
  • Epidemiology
  • Etiology and pathophysiology
  • Burden/cost/long-term disability
  • Targeted Treatment Options for NMOSD
    • Mechanisms and treatment targets
    • Therapeutic strategies: attack prevention
    • Recently approved therapeutic options
  • Satralizumab, eculizumab, inebilizumab; safety, efficacy, and recent clinical trial results
  • Open label extensions: longer-term results
    • Considerations for treatment selection
  • Developing individualized evidence-based management strategies for patients with NMOSD
  • Multidisciplinary team-based approaches to patient management
  • Controversial and Challenging Issues in NMO: Faculty Discussion
  • Voices of NMOSD – Patient Perspectives and Experiences
  • Conclusions and Q&A

This symposium is neither sponsored nor endorsed by the Consortium of Multiple Sclerosis Centers.

Learning Objectives

After completing in this educational initiative, clinicians should be better able to:

  • Establish a diagnosis of NMOSD by using guideline-based and clinical criteria and differentiating it from other autoimmune disorders
  • Compare and contrast the mechanisms of action, efficacy, safety, and tolerability of FDA-approved agents for NMOSD
  • Leverage the patient’s symptoms, quality of life, comorbidities, and other factors to select NMOSD treatment for the best possible individualized outcomes

Target Audience

This activity is intended to meet the educational needs of U.S.-based neurologists, ophthalmologists, neuro-ophthalmologists, optometrists, pharmacists, emergency medicine clinicians, nurses, nurse practitioners, and physician assistants who diagnose and manage patients with NMOSD.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

Med Learning Group designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)TM

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Nursing Credit Information

Purpose: This program would be beneficial for nurses involved in the care of patients with NMOSD. CNE Credits: 1.25 ANCC Contact Hour(s).

Accreditation Statement

Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.25 contact hour(s) of continuing nursing education of RNs and APNs.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (ie, physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Release date: June 01, 2022
Expiration date: June 01, 2023
Estimated time to completion: 1 hour